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Abstract: Proteins and peptides in mammals are based exclusively on L-amino acids. 
Recent investigations show that D-amino acids exhibit physiological effects in vivo, despite 
of their very small quantities. We have investigated the hepatoprotective effects of the L- 
and D-enantiomers of α-melanocortin peptide (α-MSH). The results showed that peptide-
enantiomerism is related to the protective effects of melanocortin peptides in vivo. L-α-
MSH exhibited potent hepatoprotective effect in the experimental model of acetaminophen 
induced hepatotoxicity in male CBA mice, while its D-mirror image was inefficient. 
Furthermore, the antibody to the L-peptide did not recognize the D-structure. The results 
indicate that the opposite peptide configuration may be used to modulate its function and 
metabolism in vivo and in vitro.  
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1. Introduction 
It has been long believed that only the L-enantiomers of amino acids are present in higher animals 
[1–5]. Recent advances in analytical chemistry and progress in peptide synthesis have however 
enabled the investigation of amino acid and peptide D-enantiomers (Figure 1), both from the 
biochemical and physiological standpoint [1,3]. Intermolecular interactions of polypeptides or 
antibodies to their receptors are known to be sterically constrained [6–9]. However, little is known on 
“how the influence of inversion of configuration of all stereogenic centers in a protein influences on its 
function?” [2]. Consequently, we performed a comparative investigation of α-melanocortin (α-MSH) 
L- and D-enantiomers with respect to their structure, in vitro binding, and in vivo protective effects. We 
have investigated α-MSH peptide because its L-enantiomer is an ancient and evolutionary conserved 
tridecapeptide hormone that exhibits well defined protective and antiinflammatory effects on different 
tissues and organs, including liver [10-12]. α-MSH derives from post-translational processing of the 
pro-opiomelanocortin (POMC) propeptide [10-12]. 
Figure 1. Representation of L- and D-amino acid structure.  
 
2. Results and Discussion 
2.1. Circular Dichroism Spectroscopy of α-MSH Enantiomers  
The circular dichroism (CD) spectra of L-α-MSH and D-α-MSH enantiomers in Figure 2 show an 
opposite sign of ellipticity degree caused by differential absorption of circular polarized light 
components proving their opposite chiral activity [13]. According to the spectral profile both peptide 
isomers in aqueous solution of sodium phosphate buffer (10 mM, pH 7.4) exhibit predominantly 
random coil structure form [14,15], having maximum ellipticity around 200 nm arising out of the π-
π transition of the peptide amide bond (Figure 2). 
2.2. Competitive Enzymatic Immunoassay (EIA) of α-MSH Enantiomers 
L-α-MSH and D-α-MSH enantiomers were quantified by means of the competitive enzymatic 
immunoassay kit (Phoenix Pharmaceuticals Inc., USA) [16,17]. Results presented in Figure 3 show 
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matching curve paterns of L-α-MSH EIA standard and tested L-α-MSH enantiomer. D-α-MSH 
enantiomer was not recognized by the competitive EIA procedure, i.e., by the primary antibody to L-α-
MSH peptide (Figure 3). 
Figure 2. CD spectra of L-α-MSH and D-α-MSH enantiomers (10 mM, pH 7.4, sodium 
phosphate buffer at peptide concentration of 0.1 mM). 
 
Figure 3. Detection of L- and D-α-MSH by means of competitive enzymatic immunoassay. 
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Our results are in line with several other reports indicating that opposite peptide configurations of 
enantiomers may be used to modulate their function, metabolism and antibody binding in vitro [6–9]. 
They support the findings of Sela and Zisman [18] that peptides consisting of D-amino acids exhibit 
stereospecific antibody responses. Benkirane et al. [8] and Guichard et al. [9] also described that 
antibody response in mice is stereospecific and subclass dependant. 
It is currently unknown if D-α-MSH enantiomer or its small fragments bind to melanocortin 
receptors. In mammalian tissues D-amino acids are first converted into the corresponding α-keto acids 
by D-amino-acid oxidase (DAO) [3,19]. During this process potentially toxic ammonia (NH3) and 
hydrogen peroxide (H2O2) are produced [3]. In the second step α-keto acids are stereospecifically 
converted to their corresponding L-amino acids by transaminases [19]. Consequently, the process of 
D→L amino acid conversion may influence hepatocyte metabolism and function.  
2.3. Treatment of Hepatotoxicity with α-MSH Enantiomers 
Acetaminophen (APAP) produces liver lesions in two phases - intrinsic and extrinsic. In the 
intrinsic phase the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) covalently binds to 
important intracellular proteins which leads to damage of centrilobular regions of liver [20,21]. In the 
extrinsic phase the release of intracellular content is accompained with liberation of numerous 
cytokine and chemokine mediators from nonparenchymal and nonhepatic cell types [20]. The final 
result is the strong inflammatory response of the liver, and the model is a well known screening model 
for hepatoprotective drugs [20,21]. The effect of tested substances is estimated by plasma alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST) activity measurement and 
histopathological grading of liver lesions [20,21].  
L-α-MSH enantiomer exhibited hepatoprotective dose dependent effects (Tables 1-3). ALT and 
AST were significantly lower in the group trested with 2.5 mg/kg of L-α-MSH with respect to the 
control group treated with 0.9% NaCl (Tables 1-2). D-α-MSH enantiomer did not show any protective 
effects. Biochemical findings of L-α-MSH hepatoprotection and D-α-MSH inefficiency were 
confirmed by the histopatological grading of the lesions (Table 3). The results show that only naturally 
occurring L-α-MSH peptide has protective effects on liver damage. This is in line with the protective 
effects of L-α-MSH reported for thioacetamide-, carbon tetrachloride- and endotoxin-induced liver 
lesions [22-24]. 
The histological changes seen in acetaminophen poisoning are centrilobular hepatic necrosis and 
sinusoidal congestion. In severe cases with scores 3-5 (Figure 4, Table 3) submassive (bridging) or 
panacinar (massive) necrosis is seen [25,26]. This pattern of necrosis reflects the role of P450 isozyme 
for bioactivation (CYP2E1), which is concentrated in this part of the hepatic acinus, as well as the fact 
that glutathione levels are lower in centrilobular zone [25–26]. Inflammation is not a significant 
feature of severe lesions because the necrosis unables quantification of the infiltrate [26]. 
Inflammatory infiltrate is seen in the groups with mild lesions and lack of necrosis, i.e., in groups with 
scores 1-2 (Figure 4, Table 3). L-α-MSH exerts its antiinflammatory effects by activating melanocortin 
receptors, leading to adenyl cyclase activation and subsequent increase of intracellular cAMP 
concentration [11,12]. This prevents activation of nuclear factor κB, and subsequently leads to 
reduction of pro-inflammatory mediators synthesis and adhesion molecules expression [11,12]. 
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Table 1. Aspartate aminotransferase activity (U/L) in plasma of the control and α-MSH 
treated animals 24 h after acetaminophen administration. 
Substance i.p. dose Mean SD Median P value 
Control 0.9% NaCl 6767.25 6468.60 5434.0  
L-α-MSH 0.10 mg/kg 4880.43 3891.38 3691.0 >0.999 
L-α-MSH 0.50 mg/kg 2613.88 1114.85 2368.5 >0.999 
L-α-MSH 1.00 mg/kg 1418.50 1228.44 905.5 0.587 
L-α-MSH 2.50 mg/kg 539.50 459.62 414.0 0.031 
D-α-MSH 0.10 mg/kg 1756.21 1031.83 1940.0 0.996 
D-α-MSH 0.50 mg/kg 3774.53 2082.77 3460.0 >0.999 
D-α-MSH 1.00 mg/kg 3082.32 2810.30 3730.0 0.806 
D-α-MSH 2.50 mg/kg 2754.30 1388.61 3400.0 0.999 
Table 2. Alanine aminotransferase activity (U/L) in plasma of the control and α-MSH 
treated animals 24 h after acetaminophen administration. 
Substance i.p. dose Mean SD Median P value 
Control 0.9% NaCl 9550.00 9213.15 7321.5  
L-α-MSH 0.10 mg/kg 8983.67 4654.38 7901.0 0.998 
L-α-MSH 0.50 mg/kg 4292.00 1422.14 3945.0 >0.999 
L-α-MSH 1.00 mg/kg 2671.25 2235.06 2167.5 0.589 
L-α-MSH 2.50 mg/kg 585.75 1424.17 89.0 0.023 
D-α-MSH 0.10 mg/kg 3602.50 2068.51 3820.0 0.996 
D-α-MSH 0.50 mg/kg 5752.22 1847.53 5630.0 >0.999 
D-α-MSH 1.00 mg/kg 5162.47 4226.78 6480.0 0.808 
D-α-MSH 2.50 mg/kg 4932.86 2238.02 5580.0 >0.999 
Table 3. Intensity of liver lesions 24 h after acetaminophen administration in controls and 
α-MSH treated animals. 
Substance i.p. dose Mean SD Median P value 
Control 0.9% NaCl 4.00 1.20 4.5  
L-α-MSH 0.10 mg/kg 4.17 0.98 4.5 0.999 
L-α-MSH 0.50 mg/kg 3.33 0.52 3.0 0.560 
L-α-MSH 1.00 mg/kg 2.29 0.49 2.0 0.032 
L-α-MSH 2.50 mg/kg 2.00 0.76 2.0 0.018 
D-α-MSH 0.10 mg/kg 4.40 0.89 5.0 0.997 
D-α-MSH 0.50 mg/kg 4.60 0.55 5.0 0.971 
D-α-MSH 1.00 mg/kg 4.20 1.10 5.0 >0.999 
D-α-MSH 2.50 mg/kg 4.89 0.38 5.0 0.506 
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Figure 4. Histopathological analysis of liver sections using a light microscopy 
(hematoxilin and eosin staining, magnification ×200). Presence and intensity of lesions was 
graded on a scale from 0 to 5. 0 = no lesions ; 1 = minimal lesions, isolated necrotic cells;  
2 = mild lesions, from 10% to 25% of necrotic cells or mild diffuse degenerative changes; 
3 = moderate lesions, from 25 to 40% of necrotic cells; 4 = marked lesions, from 40 to 
50% of necrotic cells; 5 = severe lesions, more than 50% of necrotic cells. 
 
3. Experimental 
3.1. Circular Dichroism Experiment 
The circular dichroism spectra were acquired at room temperature with a Jasco J-810 CD 
spectropolarimeter using quartz precision cells of 0.2 mm path length. The following scan parameters 
were used: high sensitivity (5 mdeg), 1-nm bandwidth, 1-s response time, 0.2-nm step resolution and 
50 nm/min. scan speed. Spectrum was an average of five continuous scans, measured between 190 and 
250 nm. L-α-MSH and D-α-MSH isomer samples (>95% purity; GenScript, USA) were prepared for 
the analysis by stock solution 1:50 dilution into sodium phosphate buffer (10 mM, pH 7.4), to give a 
final peptide concentration of 0.1 mM. The acquired spectra were corrected by subtracting blank runs 
on peptide-free sodium phosphate buffer using JASCO proprietary software Spectra Analysis version 
1.53.04 and presented as the ellipticity in degrees without normalization.  
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3.2. Quantification of α-MSH Enantiomers by Means of Competitive EIA  
L-α-MSH and D-α-MSH enantiomers were quantified by means of a commercially available 
competitive enzymatic immunoassay kit (Phoenix Pharmaceuticals Inc., USA) [16,17]. First, L-α-MSH 
standard, L-α-MSH and D-α-MSH were added to microtiter plate wells pre-coated with secondary 
antibody. Primary antibody and then biotinylated L-α-MSH were added. After 2-hour incubation 
supernatants were discarded and wells were washed. Then, solution of horseradish peroxidase bound 
to streptavidin (SA-HRP) was added, system was incubated 1 hour and washed further. The  
3,3’,5,5’-tetramethylbenzidine (TMB) substrate solution was added in dray wells and incubated for 1 
hour. By addition of 2 N HCl blue substrate colour was changed to yellow and the absorbance (optical 
density) was read at 450 nm. α-MSH concentrations were expressed as ng/mL (minimum detectable 
concentration = 0.14 ng/mL, as indicated by the manufacturer) [16]. 
3.3. Animals 
Experimental animals were male CBA mice, 12–16 weeks old, weighing 20–25 g and bred at the 
Ruđer Bošković Institute. The animals were kept in a room with constant temperature (22 ± 1 °C) and 
dark-light cycle (12h/12h). Mice were food-fasted with free access to water 24 hours prior to inducing 
liver damage by acetaminophen. Four hours after the substance administration they were fed by 
standard laboratory food and given water ad libitum.  
3.4. Treatment Regimen (Hepatotoxicity Model) 
Hepatotoxicity was induced following the procedure described by Guarner et al. [27], with slight 
modifications [28]. To induce hepatic drug-metabolizing enzymes mice were given phenobarbitone-
sodium (Kemika, Zagreb, Croatia) in their drinking water for 7 days in a dose of 0.3 g/L. Thereafter, 
mice were fasted overnight and acetaminophen (Krka, Novo Mesto, Slovenia) 150 mg/kg was given 
intragastrically (i.g.), via a gastric tube, in a volume of 0.5 mL. Mice were re-fed after 4 hours. All 
tested substances were given intraperitoneally (i.p.) 1 hour before acetaminophen administration, in a 
volume of 0.2 mL. Control animals were treated with saline (0.9% NaCl). The size of experimental 
groups was 6–8. Mice that spontaneously died were excluded from histopathological or biochemical 
analysis. 
3.5. Test Compounds 
L- and D-enantiomers of α-MSH (Ac-SYSMEHFRWGKPV-NH2, >95% purity; GenScript, USA), 
were administered intraperitonealy (i.p.) in four progressive doses (0.1 mg/kg, 0.5 mg/kg, 1.0 mg/kg 
and 2.5 mg/kg) dissolved in 0.9% NaCl 1 hour prior to the administration of APAP. 
3.6. Histopathological Estimation of Liver Damage 
Sections of the liver were fixed in 10% phosphate buffered formalin, embedded in paraffin, 
sectioned at 4 µm, and stained with hematoxilin and eosin. Sections were examined by using light 
microscope at ×100 magnification. Grading of the liver lesions from 0-5, proposed by Silva et al. [29] 
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was applied: 0 = no lesions detected; 1 = minimal lesions, isolated necrotic cells; 2 = mild lesions, 
from 10% to 25% of necrotic cells or mild diffuse degenerative changes; 3 = moderate lesions, from 25 
to 40% of necrotic cells; 4 = marked lesions, from 40 to 50% of necrotic cells; 5 = severe lesions, more 
than 50% of necrotic cells. Lesions of 3 and more points were considered to be a significant liver 
damage. 
3.7. Plasma Transaminase Activity 
Mice were sacrificed 24 hours after acetaminophen application. Alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) activity was determined from plasma by standard laboratory 
techniques. Plasma was separated by centrifugation for 5 min at 8,000 g, and was stored at −20 °C for 
24 h before transaminase activity determination. 
3.8. Data Analysis 
Statistical analysis was performed with KyPlot Software (version 4.0). Kruskall-Wallis test and 
Steel’s test (P, Tables 1-3) were used to test the differences between effects of applied neuropeptide 
doses and control group (0.9% NaCl). All applied tests were two-tailed. P ≤ 0.05 were considered as 
statistically significant. 
4. Conclusions 
(1). Both enantomers of α-MSH peptide, when diluted 1:50 in sodium phosphate buffer (10 mM,  
pH 7.4), exhibit predominantly random coil structure. 
(2). Antibody to L-α-MSH did not recognize D-α-MSH enantiomer. 
(3). L-α-MSH enantiomer was hepatoprotective in the experimental model of acetaminophen induced 
hepatotoxicity in male CBA male mice, while D-α-MSH was inefficient. 
(4). Peptide-enantiomerism should be considered in the investigations of peptide bio- and immuno-
reactivity.  
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